Refine
Year of publication
- 2010 (5) (remove)
Document Type
- Doctoral Thesis (5)
Language
- English (5) (remove)
Has Fulltext
- yes (5)
Is part of the Bibliography
- no (5)
Keywords
- Gerichtete Evolution (2)
- Proteindesign (2)
- Alkohol (1)
- Alkohole (1)
- Arylesterase (1)
- Arzneimitteldesign (1)
- Biokatalyse (1)
- Biokonversion (1)
- Biotechnologie (1)
- DNA-Wirkstoff-Interaktion (1)
- DNA-Wirkstoff-Struktur (1)
- DNA-drug interaction (1)
- DNA-drug structure (1)
- DNS (1)
- Durchflusscytometrie (1)
- Enantioselektivität (1)
- Enzym (1)
- Esterasen (1)
- High throughput screening (1)
- Protein engineering (1)
- RNS-Synthese (1)
- Substratspezifität (1)
- Thermodynamik (1)
- biocatalysis (1)
- enzyme (1)
- gamma-Lactamase (1)
- gamma-lactamase (1)
- in vivo selection (1)
- pyrrolobenzodiazepine (1)
- tertiary alcohol (1)
- tertiärer Alkohole (1)
Institute
- Institut für Chemie und Biochemie (5) (remove)
The focus of this thesis is the engineering and analysis of the enantioselectivity of esterases using 3-phenylbutyric acid (3-PBA) as model substrate. An ultra high throughput assay for identification of enantioselective esterases has been developed, based on the combination of in vivo selection and flow cytometry. The in vivo selection medium consists of a couple of pseudo-enantiomers of 3-PBA; one enantiomer is coupled to glycerol (GE), and hydrolysis of this substrate will enable cell survival. The other enantiomer is coupled to the toxin 2,3-dibromopropanol (BE), the hydrolysis of this substrate will cause cell death. Thus, cell survival is a function of the enantioselectivity of the enzyme expressed. The pseudo-enantiomeric substrates are structurally similar to allow selection for enantioselectivity instead of selection for enzyme substrate affinity. Next, esterase BS2 was chosen as negative control to establish the selection system since it hydrolyses both pseudo-enantiomers with low enantioselectivity (E~3 and 1, respectively). High enantioselective esterases towards 3-PBA: esterases PestE and CL1 (E > 100, both (R)-selective) were identified in a screening and used as positive controls. Further, the hyperthermophilic esterase PestE was crystallized. After elucidation of the enzyme structure, the high enantioselectivity of the enzyme towards 3-PBA could be explained by molecular modelling. The optimal concentration of the pseudo-enantiomeric substrates was set to be 5 mM for GE (higher concentrations were toxic) and 20 mM for BE (lower concentrations did not completely inhibit bacterial growth). The in vivo selection system was established together with the identification of a flow cytometric method to differentiate bacterial physiological status. The combination of Syto9 and PI was chosen as staining technique, because it allowed differentiation of the viable and the dead cell populations, and of these from the background. After viability detection by flow cytometry was established, esterases PestE and BS2 were cultivated in selection ((R)-GE and (S)-BE) and anti-selection medium ((S)-GE and (R)-BE). Clear differences in the culture viability depending on the enantioselectivity of the enzyme expressed appeared: cells expressing the (R)-enantioselective PestE could proliferate in selection medium, but could not proliferate in anti-selection medium. Cells expressing the non-selective BS2 did not grow in any media. Further, cultures containing mixtures of BS2/PestE or BS2/CL1 expressing cells were incubated in selection and anti-selection medium, and the viable clones were detected by flow cytometry analysis, sorted out and plated on agar. When the mixtures were incubated in selection medium, enrichment of the (R)-selective enzyme (PestE or CL1) over the non-selective enzyme (BS2) was observed. When the enzyme mixtures were incubated in anti-selection medium, very few colonies grew on agar, indicating that cell survival was a function of enzyme enantioselectivity. The successfully developed assay was used to identify variants with increased enantioselectivity in a mutant library of esterase PFEI (E ~ 3, (R)-selective) created by saturation mutagenesis. After library expression, 108 clones were in vivo selected and analyzed by flow cytometry. The viable cells were sorted out and plated on agar. The 28 resulting colonies were transferred to one microtiterplate and their activity and enantioselectivity (Eapp) was investigated using p-nitrophenyl derivatives. Four interesting mutants were identified: Table 1. Enantioselectivity of the in vivo selected mutants. Mutant Eapp[a]Etrue[b]Etrue[c]Etrue[d]Etrue[e] Mutations C4 80 4 4 3 1 V121I, F198G, V225A E7 >100 2 n.d. 3 n.d. V121S E8 2 25 16 50 >100 V121S, F198G, V225A F5 5 13 15 18 80 F121I, F198C [a] with separate (R)- or (S)-enantiomers of p-nitrophenyl-3-phenylbutanoate. [b] towards GE with cell lysate or [c] pure enzyme. [d] towards Et-3-PB with cell lysate or [e] pure enzyme. n.d. not determined. The mutants were purified and activity and enantioselectivity were determined in kinetic resolutions towards Et-3-PB and GE (Table 1). Mutants identified as highly enantioselective in the Eapp-assay (C4 and E7) were low selective in kinetic resolutions. On the contrary, mutants E8 and F5, which showed low enantioselectivity towards p-nitrophenyl-3-phenylbutanoate, hydrolyzed the 3-phenylbutyric esters with good to excellent enantioselectivities. This confirms that Eapp values can differ much from Etrue values as “you get what you screen for”, and supports that the here described method is very suitable for identification of enantioselective esterases. In this PhD thesis a novel strategy for identification of enantioselective esterases has been developed. This method allows a very high throughput (≥ 108 mutants/day) and opens the bottleneck of variant analysis, which exists in protein engineering technology.
Tertiary alcohols have become interesting targets for organic synthesis themselves or as building blocks for valuable pharmaceutical compounds. However, the synthesis of optically pure tertiary alcohols is still a challenge both chemical and enzymatic means. Enzymes containing the GGG(A)X motif in the active site region have been known to show activity towards these sterically demanding substrates. Several tertiary alcohols have been resolved with high enantioselectivity by using this biocatalytic synthetic route. This thesis aims at providing a better understanding of enantiorecognition of GGG(A)X motif hydrolases in the enzymatic synthesis of enantiomerically enriched tertiary alcohols. Kinetic resolution of a wide range of tertiary alcohols using hydrolases provided insights on factors that can influence enantioselectivity of GGG(A)X motif enzymes. Additionally, a newly proposed chemoenzymatic method to synthesize protected alpha,alpha-dialkyl-alpha-hydroxycarboxylic acids has broadened the application of these enzymes to synthesize optically pure tertiary alcohols. Newly found biocatalysts through functional screening, database mining and rational protein design approaches provided a better enzyme platform for optically pure tertiary alcohol resolution.
The aim of this thesis was to validate a method called OSCARR for One-pot, Simple Cassette Randomization and Recombination for focused directed evolution, which had been developed by Dr. Hidalgo. It is based upon the megaprimer PCR method using outer primers differing in TM and including asymmetric cycles before the addition of the forward primer to generate more mutated megaprimer. As mutation-carrying primers, spiked oligonucleotides are employed. These spiked oligonucleotides are designed using an algorithm and have strictly defined composition of nucleotides at each position. An OSCARR library of the Pseudomonas fluorescens esterase I (PFE I) of approximately 8000 clones was generated and screened for altered chain-length selectivity. Two mutants with higher activity towards medium chain length p-nitrophenyl esters were identified, both carried the mutation F126I, which causes the substrate entrance tunnel to be widened, thus facilitating access of bulkier substrates to the active site. One mutant carried the additional mutation G120S which completes a catalytic tetrad which is observed mainly in proteases. F126I had a stronger influence on chain-length specificity, so the further amino acids which form the “bottleneck” to the active site were mutated to further widen the entrance, and mutants with improved activity were found. The bottleneck mutants which consist of single, double, triple and quadruple mutants which are mostly combinations of F126L, F144L, F159L and I225L were then assayed for altered enantioselectivity against chiral acids and secondary alcohols. For substrates 1-phenyl-1-propyl acetate (2), 1-phenyl-2-propyl acetate (3) and 1-phenyl ethyl acetate (4), mutants with increased enantioselectivity were found. I225L plays a crucial role, as it is vital for enantioselectivity against 3, but destroys selectivity against 2, both facts obvious from the comparison of the triple mutant without I225L (mutant T3) and the corresponding quadruple mutant including I225L (mutant Q). However, the single mutant I225L alone does not possess high selectivity against 3, so synergistic effects play an important role. The PFE I wild type already possesses a good enantioselectivity in the hydrolysis of 4, but all mutants which were analyzed in detail surpass the wild type. The program YASARA was then used to calculate docking solutions for both enantiomers of 2 and 3 into the wild type and the best mutant. The results revealed that the mutants’ widened bottleneck allows the phenyl moiety of the substrates to point towards the access tunnel, while only (R)-2 does so in the wild type. Residues 126 and 144 do not come very close to the substrate and are more likely to influence substrate diffusion. Another goal was to find a way to confer promiscuous amidase activity upon the PFE I. In the search for structural homologues, a close structural neighbour with amidase activity was found. The --lactamase from Aureobacterium sp. was named after its activity toward the Vince lactam 2-azabicyclo[2.2.1]hept-5-en-3-one. Biocatalysis experiments with the PFE I and its mutants revealed an excellent enantioselectivity against the ( )-lactam. Specific activities were determined for purified proteins, and the activity of some mutants was within the same order of magnitude as lactamase’s activity.
Pyrrolobenzodiazepines (PBDs) are a group of antitumor antibiotics that exert their biological activity by alkylation of guanine bases within the minor groove of double-stranded DNA through nucleophilic attack of the guanine amino group on the PBD imine functionality. In trying to increase both the binding strength and sequence selectivity for further enhancing their biological activity, PBDs were linked to additional DNA binding moieties. Preliminary DNA melting experiments partly also performed in our lab with a series of closely related PBD-naphthalimide and benzimidazole conjugates revealed extraordinary DNA-binding capability of hybrids PBD-NIM and PBD-BIMZ. These studies also indicated the favorable contribution of the piperazine structure on drug binding to the DNA duplex. Previously, in vitro cytotoxicity studies also showed promising antitumor activity of both compounds with PBD-BIMZ having the largest cytotoxic potential among various examined conjugates. In the present work, the kinetics, thermodynamics and structural details of the drug-DNA interactions have been determined employing a variety of spectroscopic, calorimetric and computational methods. Thus, a high thermal duplex stabilization upon DNA binding could be ascertained for both drugs and attributed to their covalent attachment to the DNA guanine bases. The 1:1 binding stoichiometry as well as the exclusive minor groove binding for the benzimidazole and the mixed minor grove - intercalative type of binding for the naphthalimide hybrid could be verified by several spectroscopic methods including NMR spectroscopy. Furthermore, by using a combination of solution NMR and some of the most recent molecular modeling techniques, the first high-resolution structures of DNA-drug complexes with PBD hybrid drugs could be obtained giving detailed insight into the specific drug-DNA interactions. Thus, details on van der Waals and hydrogen bond contacts within the complex and the tight fit of the benzimidazole hybrid into the DNA minor groove could be revealed. By using recent data analysis techniques like clustering algorithms, the high flexibility of the piperazine moiety within the PBD-BIMZ-DNA complex could be nicely captured and visualized. Additionally, a thermodynamic analysis for the non-covalent drug binding by UV and fluorescence spectroscopy as well as by direct calorimetric methods revealed a 1:1 binding mode driven by enthalpy changes and counteracted by unfavorable entropic contributions to result in moderately strong association constants. Analysis of the solvent-accessible surface area confirmed the importance of hydrophobic effects on drug binding and the combination of these data with ITC measurements allowed for an extensive thermodynamic characterization of the drug binding process. With respect to the influence of the individual drug moieties on DNA binding, the importance of the piperazine ring for drug-DNA interactions and the basis for its capability to enhance drug binding were addressed. Furthermore, it could be shown that the naphthalimide and benzimidazole moieties also impart additional sequence selectivity to the alkylating PBD structural unit and these distinct differences in the sequence selectivity could be linked to the three-dimensional structures of the DNA-drug complexes. Clearly, the combination of detailed structural and thermodynamic data of complex formation allows for a better understanding of the binding mechanism and structure-activity relationship when it comes to drug-DNA interactions. Therefore, the information gathered can assist in the design of more efficient derivatives of this type of alkylating DNA binding drugs in particular and of DNA recognition by ligands composed of several motifs in general.